FDA Inspection 1030331 — Takeda Manufacturing Singapore Pte. Ltd.
The FDA completed an inspection of Takeda Manufacturing Singapore Pte. Ltd. on September 29, 2017 in Singapore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 29, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Singapore (Singapore)